These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
634 related items for PubMed ID: 2894298
21. Synthesis and vectorial export of cGMP in airway epithelium: expression of soluble and CNP-specific guanylate cyclases. Geary CA, Goy MF, Boucher RC. Am J Physiol; 1993 Dec; 265(6 Pt 1):L598-605. PubMed ID: 7506495 [Abstract] [Full Text] [Related]
22. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Soares TJ, Coimbra TM, Martins AR, Pereira AG, Carnio EC, Branco LG, Albuquerque-Araujo WI, de Nucci G, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Proc Natl Acad Sci U S A; 1999 Jan 05; 96(1):278-83. PubMed ID: 9874809 [Abstract] [Full Text] [Related]
23. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide. Moritoki H, Yoshikawa T, Hisayama T, Takeuchi S. Eur J Pharmacol; 1992 Jan 07; 210(1):61-8. PubMed ID: 1350988 [Abstract] [Full Text] [Related]
24. Diuretics modify [Arg8]vasopressin-stimulated cAMP but not atrial natriuretic peptide-stimulated cGMP formation in renal cells. Kanda K, Miyamoto N, Seo H, Ogawa K, Hatano T, Matsui N. Eur J Pharmacol; 1991 Jan 03; 192(1):153-9. PubMed ID: 1645672 [Abstract] [Full Text] [Related]
25. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line. Nambi P, Whitman M, Gessner G, Aiyar N, Crooke ST. Proc Natl Acad Sci U S A; 1986 Nov 03; 83(22):8492-5. PubMed ID: 2430290 [Abstract] [Full Text] [Related]
26. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ. Br J Pharmacol; 2003 Aug 03; 139(7):1289-96. PubMed ID: 12890708 [Abstract] [Full Text] [Related]
27. Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs. Bowman ME, Robinson PJ, Smith R. J Neuroendocrinol; 1997 Dec 03; 9(12):929-36. PubMed ID: 9468018 [Abstract] [Full Text] [Related]
28. Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria. Wen JF, Quan HX, Zhou GH, Cho KW. Regul Pept; 2007 Aug 16; 142(3):123-30. PubMed ID: 17531330 [Abstract] [Full Text] [Related]
29. N omega-nitro-L-arginine: a potent inhibitor of the L-arginine-dependent soluble guanylate cyclase activation pathway in LLC-PK1 cells. Ishii K, Kerwin JF, Murad F. Can J Physiol Pharmacol; 1990 Jun 16; 68(6):749-51. PubMed ID: 1973629 [Abstract] [Full Text] [Related]
30. Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase. Leitman DC, Agnost VL, Tuan JJ, Andresen JW, Murad F. Biochem J; 1987 May 15; 244(1):69-74. PubMed ID: 2889449 [Abstract] [Full Text] [Related]
31. Effects of atrial natriuretic factor and vasopressin on cyclic nucleotides in cultured kidney cells. Náray-Fejes-Tóth A, Carretero OA, Fejes-Tóth G. Hypertension; 1988 Apr 15; 11(4):392-6. PubMed ID: 2833439 [Abstract] [Full Text] [Related]
32. Adenosine 5'-triphosphate, phorbol ester, and pertussis toxin effects on atrial natriuretic peptide stimulation of guanylate cyclase in a human renal cell line. Shigematsu Y, Vaughn J, Frohlich ED, Cole FE. Life Sci; 1994 Apr 15; 54(3):213-21. PubMed ID: 7904711 [Abstract] [Full Text] [Related]
33. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. Nonoguchi H, Knepper MA, Manganiello VC. J Clin Invest; 1987 Feb 15; 79(2):500-7. PubMed ID: 3027127 [Abstract] [Full Text] [Related]
34. Regulation of human erythrocyte Na+/H+ exchange by soluble and particulate guanylate cyclase. Petrov V, Lijnen P. Am J Physiol; 1996 Nov 15; 271(5 Pt 1):C1556-64. PubMed ID: 8944639 [Abstract] [Full Text] [Related]
35. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. Bouley R, Breton S, Sun T, McLaughlin M, Nsumu NN, Lin HY, Ausiello DA, Brown D. J Clin Invest; 2000 Nov 15; 106(9):1115-26. PubMed ID: 11067864 [Abstract] [Full Text] [Related]
36. Interaction of atrial natriuretic peptide-stimulated guanylate cyclase and vasopressin-stimulated calcium signaling pathways in the glomerular mesangial cell. Kremer S, Troyer D, Kreisberg J, Skorecki K. Arch Biochem Biophys; 1988 Feb 01; 260(2):763-70. PubMed ID: 2449131 [Abstract] [Full Text] [Related]
37. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Kumar R, Cartledge WA, Lincoln TM, Pandey KN. Hypertension; 1997 Jan 01; 29(1 Pt 2):414-21. PubMed ID: 9039136 [Abstract] [Full Text] [Related]
38. Presence of functional type B natriuretic peptide receptor in human ocular cells. Pang IH, Shade DL, Matsumoto S, Steely HT, DeSantis L. Invest Ophthalmol Vis Sci; 1996 Aug 01; 37(9):1724-31. PubMed ID: 8759339 [Abstract] [Full Text] [Related]
39. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats. Reis WL, Giusti-Paiva A, Ventura RR, Margatho LO, Gomes DA, Elias LL, Antunes-Rodrigues J. Exp Physiol; 2007 Sep 01; 92(5):903-11. PubMed ID: 17513344 [Abstract] [Full Text] [Related]
40. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus. Boone M, Kortenoeven M, Robben JH, Deen PM. Nephrol Dial Transplant; 2010 Jan 01; 25(1):48-54. PubMed ID: 19666909 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]